Paper Details

  1. Home
  2. Paper Details

Management of non-metastatic castrate-resistant prostate cancer: A systematic review.

Author: BarthélémyPhilippe, BeauvalJean-Baptiste, BorchielliniDelphine, GrossEmmanuel, LoriotYohann, MailletDenis, PasticierGilles, PignotGéraldine, PloussardGuillaume, SargosPaul, SchlürmannFriederike, SupiotStéphane, TimsitMarc-Olivier, VincendeauSébastien

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Treating prostate cancer that has spread but not to distant areas (non-metastatic castrate resistant prostate cancer) is challenging because it is a variable disease, and there is limited research. New hormone therapies, apalutamide and enzalutamide, have shown promise. This review examines the available treatment options for this type of cancer.
Paper Details　
Original Abstract of the Article :
Management of non metastatic castrate resistant prostate cancer is challenging for clinicians due to the heterogeneity of the disease and to the scarce clinical data available in this setting. Recent results obtained with the new generation hormone therapies (NGHT) apalutamide and enzalutamide bring...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/j.ctrv.2018.09.006

データ提供：米国国立医学図書館（NLM）

Navigating the Shifting Sands of Prostate Cancer

The treatment of prostate cancer, a disease that affects the male reproductive system, is a challenging and evolving landscape, my friends. It's like a desert, constantly shifting with new discoveries and emerging therapies. This study reviews the current management options for non-metastatic castrate-resistant prostate cancer, a particularly challenging form of the disease. The researchers examine the existing treatment strategies and highlight the potential of new-generation hormone therapies. Their study is like a caravan carefully surveying the desert, seeking to identify the most promising paths for treatment.

New-Generation Hormone Therapies: A Hopeful Oasis

The study emphasizes the potential of apalutamide and enzalutamide, new-generation hormone therapies, in the treatment of non-metastatic castrate-resistant prostate cancer. These drugs have shown promising results in clinical trials, offering a new hope for patients with this aggressive form of the disease. It's like finding a hidden oasis in the desert, providing a source of relief and rejuvenation.

The Ongoing Quest for Better Treatments

This study underscores the ongoing quest for effective treatments for prostate cancer. As researchers continue to explore the desert of prostate cancer, we can expect to see further advancements in treatment strategies, leading to better outcomes for patients. It's a reminder that the journey towards a cure is a continuous process, requiring ongoing research and innovation to improve the lives of those affected by this disease.

Dr.Camel's Conclusion

This study provides a comprehensive overview of the current management options for non-metastatic castrate-resistant prostate cancer, highlighting the potential of new-generation hormone therapies. As research continues to evolve, we can anticipate more effective treatments that will improve the lives of those facing this challenging disease. It's a testament to the enduring power of science and its unwavering commitment to improving human health.

Date :
  1. Date Completed 2018-11-20
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

30300771

DOI: Digital Object Identifier

10.1016/j.ctrv.2018.09.006

Related Literature

Article Analysis
・Effective treatment of prostate cancer
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.